01 June,2022

To

Phiroze Jeejeebhoy

Exchange Plaza,

BSE Limited

National Stock Exchange of India Limited

Towers, Dalal Street,

Bandra Kurla Complex,

Mumbai - 400 001

Bandra (E), Mumbai - 400

051

Scrip code: 541540

Scrip code: SOLARA

S. Murali Krishna

Company Secretary & Compliance Officer

Solara Active Pharma Sciences Limited

2nd Floor, Admin Block,

27, Vandaloor, Kelambakkam Road,

Keelakottaiyur Village, Melakottaiyur PO

Chennai - 600127

Dear Sir/ Madam,

Sub: Disclosure under Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 with respect to proposed inter-se transfer of equity shares of Solara Active Pharma Sciences Limited

Pursuant to Regulation 10(5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 ('SEBI SAST Regulations'), kindly find enclosed herewith disclosure in the prescribed format with respect to proposed inter-se transfer of equity shares of Solara Active Pharma Sciences Limited, through an off-market transaction.

Kindly take the same on record.

Thanking you,

Yours faithfully,

JYOTHINAGARAVY ASHA SRIRAMAN RAMAPRASAD

Digitally signed by

JYOTHINAGARAVYASHA

SRIRAMAN RAMAPRASAD

Date: 2022.06.01 18:40:08 +05'30'

Jyothinagaravyasha Sriraman Ramaprasad

Designated Partner

Devicam Capital LLP

Encl.: A/a

Disclosures under Regulation 10(5)- Intimation to Stock Exchanges in respect of

acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares and

Takeover Regulations, 2011

1.

Name of the Target Company (TC)

Solara Active Pharma Sciences Limited

2.

Name of the acquirer(s)

Devicam Capital LLP

3.

Whether the acquirer(s) is/ are

Yes, The Acquirer forms part of the Promoter group.

promoters of the TC prior to the

transaction. If not, nature of

relationship or

association with

the TC or its promoters

4.

Details of the proposed acquisition

a.

Name of the person(s) from

Mr. Arun Kumar Pillai

whom shares are to be

acquired

b

Proposed date of acquisition

08 June,2022 or thereafter

c.

Number of shares to be

15,00,000 shares

acquired from each person

mentioned in 4(a) above

d

%Totalof sharescapitalto be acquiredof the TCas

4.17%

share

capital of TC

e.

proposedPrice at whichto beshares are

NinetyRs. 408.9Paise/- (Rupeesonly) Fourper

Hundredshare aggregatingand Eight Decimalto Rs.

Acquired

61,33,50,000/- (Rupees Sixty-One Crores Thirty-Three

f.

Rationale, if any, for the

Lakhs Fifty Thousand Only)

Inter-se transfer of shares amongst Promoter and Promoter

proposed transfer

group

5.

Relevant sub-clause of regulation

10(1)(a)(i) of SEBI SAST Regulations

10(1)(a) under

which the acquirer is exempted

from making open offer

6.

If,

frequently

traded,

volume

Applicable

weighted average

market

price

Volume Weighted Average Market Price: Rs. 627.89/-

for a

period

of

60

trading

(Rupees Six Hundred and Twenty-Seven Decimal Eighty-Nine

days preceding the date of

Paise Only)

issuance of this notice as traded

on the stock exchange where the

maximum volume of trading in

the

shares of

the

TC

are

recorded during such

period.

7.

If in-frequently traded, the price

Not Applicable

as determined in terms of clause

(e) of sub-regulation (2) of

regulation 8.

8.

Declaration by the acquirer, that

Applicable- Declaration Attached

the acquisition price would not be

higher by more than 25% of the

price computed in point 6 or

point 7 as applicable.

9. theDeclarationhave transferorcompliedby/thewillandacquirer,complytransfereewiththat Applicable- Declaration Attached

applicabledisclosure requirements in Chapter V of the Takeover Regulations, 2011 (corresponding provisions of the repealed Takeover Regulations 1997)

allDeclarationthe conditionsby thespecifiedacquirerunderthat Applicable- Declaration Attached regulation 10(1)(a) with respect

to exemptions has been

duly complied with10.

11.

Shareholding details

transaction

transaction

Before the proposed

After the proposed

shares/votin

total share

shares/votin

total share

No. of

% wrt to

No. of

% wrt to

g rights

capital of

g rights

capital of TC

A

Acquirer(s) and PACs (other

TC

than sellers)(*)

(i)

Devicam Capital LLP

15,15,46

0.42

16,51,546

4.59

Seller (s)

B

Mr. Arun

31,68,463

8.80

4.63

(i)

Kumar Pillai

16,68,463

(*) Shareholding of each entity may be shown separately

and then collectively in a group. The above

disclosure shall be signed by the acquirer mentioning date & place. In case, there is more than one

acquirer, the report shall be signed either by all the persons or by a person duly authorized to do so

on behalf of all the acquirers.

Signature:

JYOTHINAGARAVY Digitally signed by

ASHA SRIRAMAN

JYOTHINAGARAVYASHA

SRIRAMAN RAMAPRASAD

RAMAPRASAD

Date: 2022.06.01 18:40:27

+05'30'

Jyothinagaravyasha Sriraman Ramaprasad

Designated Partner

Devicam Capital LLP

Date: 01 June,2022

Place: Bengaluru

DECLARATION

01 June,2022

We, Devicam Capital LLP (''The LLP'') hereby declare that the acquisition price Rs. 408.90/- (Rupees Four Hundred and Eight Decimal Ninety Paise only) for acquiring 15,00,000 (Fifteen Lakhs) equity shares (through Inter-se Transfer of Shares) of Solara Active Pharma Sciences Limited (''Target Company'') by the LLP is not higher than:

"Frequently traded volume weighted average market price for a period of 60 days preceding the date of issuance of notice as traded on the stock exchange where minimum volume of trading in the shares of the TC (Target Company) are recorded during such period. - (Point 6 of the Disclosure under Regulation 10 (5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.)''

For Devicam Capital LLP

JYOTHINAGARAVY ASHA SRIRAMAN RAMAPRASAD

Digitally signed by

JYOTHINAGARAVYASHA SRIRAMAN RAMAPRASAD Date: 2022.06.01 18:40:39 +05'30'

Jyothinagaravyasha Sriraman Ramaprasad

Designated Partner

DPIN: 00173696

DECLARATION

01 June,2022

We, Devicam Capital LLP (''The LLP'') hereby declare that:

1. The Transferor (Mr. Arun Kumar Pillai) and Transferee (Devicam Capital LLP) have complied/ will comply with applicable disclosure requirements in Chapter V of the Takeover Regulations, 2011 (corresponding provisions of repealed Takeover Regulations 1997.)

2. Devicam Capital LLP (The Acquirer) has complied with all the conditions specified under Regulation 10(1)(a) with respect to exemptions has been duly complied with.

For Devicam Capital LLP

JYOTHINAGARAV YASHA SRIRAMAN RAMAPRASAD

Digitally signed by

JYOTHINAGARAVYASHA SRIRAMAN RAMAPRASAD Date: 2022.06.01 18:40:49 +05'30'

Jyothinagaravyasha Sriraman Ramaprasad

Designated Partner

DPIN: 00173696

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Solara Active Pharma Sciences Ltd. published this content on 02 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 June 2022 10:01:07 UTC.